Sharon R Lewin

33PUBLICATIONS

174CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methodsRegenerative medicine (incl. stem cells)Innate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (33)

Sort by Publication Date:

|Jul 01, 2026

Targeting rapidly cycling receptors CD2 and CD7 increases nanoparticle delivery to primary CD4<sup>+</sup> T cells.

|May 12, 2026

Community Perceptions Regarding use of HIV Molecular Epidemiology for Public Health in Victoria, Australia: Qualitative Findings.

|Feb 25, 2026

Methaneseleninic acid, a circadian-modulating agent, reactivates latent HIV-1 infection without cellular activation or proliferation.

Jared Stern, Rory A Shepherd, Youry Kim

|Feb 12, 2026

Innate antiviral and immune functions associated with the HIV reservoir decay after anti-PD-1 therapy.

Aarthi Talla, Joao L L C Azevedo, Muhammad Bilal Latif

|Jan 29, 2026

The effect of combining HIV latency reversal with inhibition of phosphoinositide-3 kinases or B-cell lymphoma-2 on the HIV reservoir.

Youry Kim, Jenny L Anderson, Carolin Tumpach

|Jul 25, 2025

Opportunities and challenges for hepatitis B cure in people living with HIV and hepatitis B virus.

Kasha P Singh, Jennifer Audsley, Wei Zhao

Pageof 6

Frequent Collaborators

Michael Roche

Steven G Deeks

Nicolas Chomont

Paul U Cameron

Jeffrey V Lazarus

Rémi Fromentin

Jennifer M Zerbato

Rachel Pascoe

Natalia Laufer

Gabriela Turk

Frequent Collaborators

Michael Roche

Steven G Deeks

Nicolas Chomont

Paul U Cameron